CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.17
-0.57 (-8.46%)
Mar 31, 2025, 1:27 PM EDT - Market open
CorMedix Employees
As of December 31, 2023, CorMedix had 83 total employees, including 82 full-time and 1 part-time employees. The number of employees increased by 42 or 102.44% compared to the previous year.
Employees
83
Change (1Y)
42
Growth (1Y)
102.44%
Revenue / Employee
$523,761
Profits / Employee
-$216,024
Market Cap
402.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRMD News
- 3 days ago - CorMedix: A Fair-Priced Biotech Company With A Bright Future - Seeking Alpha
- 6 days ago - CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 days ago - CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 13 days ago - CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025 - GlobeNewsWire
- 2 months ago - CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 3 months ago - CorMedix Inc. Added to Nasdaq Biotechnology Index - GlobeNewsWire
- 4 months ago - CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products - GlobeNewsWire